Search results
Taking Stock: Market hits new milestone; bank, metal, power outshine
CNBC Awaaz· 48 minutes agoAmong sectors, except media, all other sectoral indices ended in the green with power, capital...
ICICI Lombard hits new record high on CLSA upgrade, forecasts 7% upside potential
CNBC Awaaz· 4 hours agoCLSA upgraded ICICI Lombard to 'outperform' from 'hold' and raised target price to Rs 2,000 per ...
Subscribe Emcure Pharmaceuticals Ltd; KR Choksey
CNBC Awaaz· 4 hours agoKR Choksey, has come out with its report on Emcure Pharmaceuticalss Ltd. The research firm has recommended to “ Subscribe- Long Term” the ipo in its research report as on July 02 2024.
Bansal Wire IPO: Issue subscribed 94% on Day 1 so far; retail investors frontrunners
CNBC Awaaz· 5 hours agoBansal Wire aims to raise Rs 745-crore through its public offer, with most of the proceeds aimed at...
Emcure Pharma IPO: Issue subscribed 29% on Day 1 so far; NIIs lead from the front
CNBC Awaaz· 5 hours agoA day before the drugmaker's public offer went live, Emcure Pharmaceuticals raised Rs 582.6 crore...
Diensten Tech makes powerful debut, lists with 140% premium on NSE SME
CNBC Awaaz· 6 hours agoThe profit per lot is Rs 1,68,000.
Vraj Iron and Steel makes positive debut, lists at 16% premium over IPO price
CNBC Awaaz· 6 hours agoThe Rs 171-crore initial public offering (IPO) saw remarkable investor interest over three days,...
PFC, REC get 'buy' rating from Bernstein; up to 23% upside seen in power financier stocks
CNBC Awaaz· 8 hours agoREC has delivered multibagger returns of 224 percent in one year, more than quadrupling investors'...
Trade setup for Wednesday: Top 15 things to know before the opening bell
CNBC Awaaz· 17 hours agoThe Nifty 50 is likely to consolidate as long as it stays below 24,200 on a closing basis, with...
Subscribe- Long Term Emcure Pharmaceuticals Ltd; Anand Rathi
CNBC Awaaz· 1 day agoAnand Rathi, has come out with its report on Emcure Pharmaceuticals Ltd. The research firm has recommended to “ Subscribe- Long Term” the ipo in its research report as on July 02 2024.